Examining the Effects of Ketamine Treatment on Synaptic Plasticity in Depression Using PET Imaging
Ketamine for Depression Research Study
Sponsor: Diane Goldberg Foundation
Enrolling: Male and Female Patients
Study Length: 7 Weeks
Clinic Visits: 16
IRB Number: 7847
U.S. Govt. ID: NCT04091971
Contact: Agrima Dutt, CRC: 551-239-2946 / agrima.dutt@nyspi.columbia.edu
Additional Study Information: Do you suffer from depression? Have standard treatments not been helpful? Researchers at Columbia University Irving Medical Center are conducting a study of an experimental antidepressant called ketamine, which can provide rapid relief of depressive symptoms in some patients. The study involves an inpatient stay, during which participants undergo brain imaging before and after ketamine treatment, and receive 4 intravenous infusions of ketamine over two weeks. Financial compensation of up to $600 is provided for time and effort, and outpatient psychiatric treatment is provided at no cost after ketamine treatment for a total of six months of psychiatric treatment. Please call Agrima at 551-239-2946 or email her at Agrima.Dutt@nyspi.columbia.edu if you are interested in participating or to learn more.
This study is closed
Jeffrey Miller, MD
Do You Qualify?
Are you currently depressed? Yes No
Are you between the ages of 18 - 55? Yes No
Are you available to stay at our inpatient unit for 3 weeks? Yes No
Do you currently reside in New York? Yes No
You may be eligible for this study

Place Holder

For more information, please contact:
Agrima Dutt, CRC